Literature DB >> 3778551

[Potential filaricides. Suramin analogs].

P Nickel, H J Haack, H Widjaja, U Ardanuy, C Gurgel, D Düwel, H Loewe, W Raether.   

Abstract

A series of suramin analogues has been synthesized in which the methyl groups of suramin have been replaced by hydrogen, alkyl, phenyl, and fluoro substituents, or which contain more than two methyl groups. The substances have been screened against Dipetalonema viteae in Meriones unguiculatus, Litomosoides carinii in Sigmodon hispidus and L. carinii in Mastomys natalensis, respectively. Small structural modifications have a marked influence on the antifilarial activity. There are marked differences between antifilarial and trypanocidal activities. A symmetrical molecule structure seems not to be essential for the antifilarial activity.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3778551

Source DB:  PubMed          Journal:  Arzneimittelforschung        ISSN: 0004-4172


  4 in total

1.  P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin.

Authors:  R Bültmann; H Wittenburg; B Pause; G Kurz; P Nickel; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-10       Impact factor: 3.000

2.  Gsalpha-selective G protein antagonists.

Authors:  M Hohenegger; M Waldhoer; W Beindl; B Böing; A Kreimeyer; P Nickel; C Nanoff; M Freissmuth
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

3.  The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens.

Authors:  P Sneddon; T D Westfall; L D Todorov; S M Todorova; D P Westfall; P Nickel; C Kennedy
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

4.  Suramin analogs, divalent cations and ATP gamma S as inhibitors of ecto-ATPase.

Authors:  M W Beukers; C J Kerkhof; M A van Rhee; U Ardanuy; C Gurgel; H Widjaja; P Nickel; A P IJzerman; W Soudijn
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-05       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.